Treatment of varicose veins using the Cryo laser after foam technique

IF 0.7 Q4 SURGERY

Journal of Vascular Surgery Cases Innovations and Techniques Pub Date : 2024-05-29 DOI:10.1016/j.jvscit.2024.101549

Marcos M. Fonseca MD, Faberson J. Mocelin MD, Lara R. Poltronieri MD, Jose L. Guimaraes Filho MD

{"title":"Treatment of varicose veins using the Cryo laser after foam technique","authors":"Marcos M. Fonseca MD, Faberson J. Mocelin MD, Lara R. Poltronieri MD, Jose L. Guimaraes Filho MD","doi":"10.1016/j.jvscit.2024.101549","DOIUrl":null,"url":null,"abstract":"<div><p>Sclerotherapy is the treatment of choice for telangiectasias and reticular veins. The most common side effects of this procedure are hyperpigmentation and matting, which are feared owing to their aesthetic damage and difficulty of treatment. Combined treatments with laser and hypertonic glucose sclerotherapy have been described with excellent results, but limited to treatment of veins of ≤2 mm in diameter. Cryo laser after foam sclerotherapy is a procedure to treat reticular veins in the lower extremities that utilizes first foam sclerotherapy with polidocanol than immediately followed by transdermal Nd:YAG 1064 laser treatment and we can treat veins ≤5 mm. This report presents a successful case of varicose vein treatment using combined transdermal laser and sclerotherapy with foam sclerotherapy with polidocanol to treat veins >2.5 mm in diameter.</p></div>","PeriodicalId":45071,"journal":{"name":"Journal of Vascular Surgery Cases Innovations and Techniques","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468428724001333/pdfft?md5=33c7db338fd4b117b32854a0335228f3&pid=1-s2.0-S2468428724001333-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vascular Surgery Cases Innovations and Techniques","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468428724001333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Sclerotherapy is the treatment of choice for telangiectasias and reticular veins. The most common side effects of this procedure are hyperpigmentation and matting, which are feared owing to their aesthetic damage and difficulty of treatment. Combined treatments with laser and hypertonic glucose sclerotherapy have been described with excellent results, but limited to treatment of veins of ≤2 mm in diameter. Cryo laser after foam sclerotherapy is a procedure to treat reticular veins in the lower extremities that utilizes first foam sclerotherapy with polidocanol than immediately followed by transdermal Nd:YAG 1064 laser treatment and we can treat veins ≤5 mm. This report presents a successful case of varicose vein treatment using combined transdermal laser and sclerotherapy with foam sclerotherapy with polidocanol to treat veins >2.5 mm in diameter.

查看原文本刊更多论文

使用泡沫后冷冻激光技术治疗静脉曲张

硬化疗法是治疗毛细血管扩张和网状静脉的首选方法。这种疗法最常见的副作用是色素沉着和消光，由于会损害美观且难以治疗，人们对这两种副作用感到恐惧。激光和高渗葡萄糖硬化剂疗法的联合治疗效果极佳，但仅限于治疗直径≤2 毫米的静脉。泡沫硬化剂疗法后的冷冻激光疗法是一种治疗下肢网状静脉的方法，它首先使用多聚乙醇进行泡沫硬化剂疗法，然后立即进行经皮 Nd:YAG 1064 激光治疗，我们可以治疗直径小于 5 毫米的静脉。本报告介绍了一例成功治疗静脉曲张的病例，该病例采用经皮激光和硬化剂联合疗法，再配合使用多聚乙醇的泡沫硬化剂疗法，治疗直径为 2.5 毫米的静脉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Vascular Surgery Cases Innovations and Techniques SURGERY-

CiteScore

1.00

自引率

14.30%

发文量

219

审稿时长

29 weeks

期刊介绍： Journal of Vascular Surgery Cases and Innovative Techniques is a surgical journal dedicated to publishing peer review high quality case reports, vascular images and innovative techniques related to all aspects of arterial, venous, and lymphatic diseases and disorders, including vascular trauma, malformations, wound care and the placement and maintenance of arterio-venous dialysis accesses with an emphasis on the practicing clinician. The Journal seeks to provide novel and timely information to vascular surgeons, interventionalists, phlebologists, wound care specialists, and allied health professionals involved with the management of patients with the entire spectrum of vascular disorders.